Search results
EXCLUSIVE: Man, 32, became fully paralyzed days after getting COVID. This was his 1st symptom
TODAY via Yahoo News· 6 days ago"It was a way to bridge the gap of having physical limitations but also trying to get back to that...
Hongkongers told to safeguard against ‘flesh-eating’ bacteria when in Japan
South China Morning Post· 3 days agoAn infection of the “flesh-eating” bacteria Streptococcus pyogenes, or Group A streptococcus, can...
Hawaii Health Department warns of high COVID activity
The Honolulu Star-Advertiser via Yahoo News· 7 days agoThe Hawaii Department of Health today issued a news release reminding the public to be vigilant amid high levels of COVID-19 activity in the state. DOH ...
Summer COVID surge approaches in Seattle area as travel season begins
The Columbian· 2 days agoA summer COVID-19 surge is on its way through Seattle and the region. Infection rates and emergency...
What Makes Big Pharma’s Blockbuster Product So Dangerous?
Mercola· 5 days ago1. Immune dysfunction — Vaccines frequently cause chronic autoimmune disorders and varying degrees of immune suppression. 3. Impaired circulation — Vaccines can impair fluid circulation by affecting ...
My sudden symptoms left doctors stumped—until a rare diagnosis
Newsweek· 5 days agoAlthough I didn't know it then, I'd developed Postural Orthostatic Tachycardia Syndrome, or POTS, a...
Study shows 12% long-COVID prevalence following Omicron infection
Center for Infectious Disease Research and Policy· 2 days agoThe odds ratio of any persistent symptoms was more than double in COVID-19 patients.
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 2 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
Feds Arrest Telehealth Execs for Overprescribing Adderall
Reason.com via AOL· 5 days agoRuthia He, Done's founder and CEO, and David Brody, the company's clinical president, are alleged to...
RedHill Biopharma (NASDAQ:RDHL) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com began coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research report sent to investors on Thursday. The firm issued a hold rating on the biotechnology ...